Bernard Reymann
No más puestos en curso
Origen de la red de primer grado Bernard Reymann.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Medical/Nursing Services | 13 | |
Varioptic SA
Varioptic SA Electronic ComponentsElectronic Technology Varioptic SA manufactures autofocus lens for digital imaging applications. The firm offers liquid lenses for development of electrowetting technology to create variable focus lenses with no moving parts. The company was founded by Bruno Berge in 2002 and is headquartered in Lyon, France.
4
| Subsidiary | Electronic Components | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Bernard Reymann a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
REPLIMUNE GROUP, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Scorpion Therapeutics, Inc.
Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Health Center, Inc. | Corporate Officer/Principal Corporate Officer/Principal | ||
Median Technologies, Inc.
Median Technologies, Inc. Medical/Nursing ServicesHealth Services Part of MEDIAN Technologies SA, Median Technologies, Inc. provides medical imaging services. The company is based in Burlington, MA. The CEO of the company is Fredrik Bjjorn Brag. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Director/Board Member | |
ENSIMAG | College/University | Undergraduate Degree Undergraduate Degree | |
INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
5N PLUS INC. | Other Metals/Minerals | Director of Finance/CFO | |
CANAM GROUP INC. | Metal Fabrication | Comptroller/Controller/Auditor | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
POLIGHT ASA | Electronic Components | Chief Executive Officer | |
Ecole Polytechnique | College/University | Graduate Degree | |
TEXAS INSTRUMENTS INCORPORATED | Semiconductors | Corporate Officer/Principal | |
All India Institute of Medical Sciences | College/University | Doctorate Degree | |
Rolls-Royce Plc /Electrical Transmission & Distribution Bus/ | Electric Utilities | Corporate Officer/Principal | |
University of Oxford | College/University | Corporate Officer/Principal | |
Université Paris 1 Panthéon-Sorbonne | College/University | Undergraduate Degree | |
Kapital Consulting LLC | Founder | ||
Alesi Surgical Ltd.
Alesi Surgical Ltd. Medical SpecialtiesHealth Technology Alesi Surgical Ltd. is a holding company, which engages in the manufacture and development of medical devices. It focuses on minimally invasive surgery. Alesi works with surgeons to identify, resolve issues and develops techniques for the healthcare provider. Its Ultravision is a revolutionary new system that clears surgical smoke from the visual field and prevents its release into the operating theatre during laparoscopic surgery. The company was founded by Neil Warren in 2009 and is headquartered in Cardiff, the United Kingdom. | Medical Specialties | Chief Operating Officer | |
Kodak Industrie SAS
Kodak Industrie SAS Chemicals: SpecialtyProcess Industries Part of Eastman Kodak Co., Kodak Industrie SAS is a French company that manufactures chemical products for cameras. The company is based in Chalon-sur-Saone, France. | Chemicals: Specialty | Chief Tech/Sci/R&D Officer | |
Photys Therapeutics, Inc.
Photys Therapeutics, Inc. Medical SpecialtiesHealth Technology Photys Therapeutics, Inc. is a company based in Cambridge, MA that was founded by Longwood Fund and Dr. Amit Choudhary of Brigham and Women's Hospital and the Broad Institute of MIT and Harvard. The company is advancing phosphorylation inducing chimeric small molecules (PHICs), a proprietary new class of bifunctional medicines that direct and repair protein phosphorylation to treat a range of diseases including cancer, immune, metabolic, and rare diseases. PHICs enhance the pairing of specific kinases with disease target proteins, inducing precise phosphorylation at native and/or non-native sites, modulating key functions including activation, stabilization, trafficking, localization, phospho-antigen presentation, inactivation, degradation, and interactions of proteins. The company's approach unlocks diverse classes of targets, developing a new class of medicines for precise control of protein function. The company was founded by Amit Choudhary, David Steinberg, Edward Holson, Lizzie Ngo. David Steinberg has been the CEO since incorporation. | Medical Specialties | Director/Board Member | |
KRONOS BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
TRANSLATE BIO, INC. | Biotechnology | Director/Board Member | |
AlpInvest Partners BV
AlpInvest Partners BV Investment ManagersFinance AlpInvest Partners BV (AlpInvest) is a private equity asset subsidiary AP BV, ultimately owned by The Carlyle Group, Inc founded in 2000. AlpInvest Partners BV is headquartered in Amsterdam, the Netherlands. | Investment Managers | Corporate Officer/Principal | |
JUNO THERAPEUTICS INC | Biotechnology | Director/Board Member | |
Andrew Alliance SA
Andrew Alliance SA Industrial MachineryProducer Manufacturing Andrew Alliance SA develops liquid handling solutions. Its product, Andrew, is a novel liquid handling robot designed for pipetting process. The firm's products include Andrew models, consumable dominos, protocol design, and enabling accessories. The company was founded by Piero Zucchelli, Giorgio Horak, and Antoine Jordan in March 2011 and is headquartered in Vernier, Switzerland. | Industrial Machinery | Director/Board Member | |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
FIBROGEN, INC. | Pharmaceuticals: Major | Director/Board Member | |
CropDesign NV
CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member | |
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Chairman | |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Director/Board Member | |
THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
OMEGA ALPHA SPAC | Financial Conglomerates | Chief Executive Officer | |
Rectify Pharmaceuticals LLC
Rectify Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Rectify Pharmaceuticals LLC is a biotech company that is developing positive functional modulators (PFMs) to address the underlying cause of serious ABC transporter-mediated diseases. The company is based in Cambridge, MA and was founded by Jonathan Moore. The company's team includes Xiaobing Li as Chief Development Officer, Robert Hughes as Executive Vice President of Drug Discovery and Preclinical Development, and Leif-Ann Tuohey as Senior Vice President and Head of Business Development. The company has received $100 million in Series A financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund. The CEO is Rajesh Devraj, who is also a venture partner at Atlas Venture. | Miscellaneous Commercial Services | Director/Board Member | |
Sarcoma Alliance for Research through Collaboration | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 27 |
Francia | 8 |
Canadá | 6 |
Reino Unido | 4 |
Alemania | 3 |
Sectorial
Health Technology | 24 |
Consumer Services | 7 |
Finance | 5 |
Electronic Technology | 4 |
Commercial Services | 4 |
Operativa
Director/Board Member | 103 |
Corporate Officer/Principal | 42 |
Chairman | 24 |
Independent Dir/Board Member | 22 |
Undergraduate Degree | 11 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Bernard Reymann
- Conexiones Empresas